In the life sciences sector, the challenge is rarely a lack of information. Rather, the difficulty lies in compiling the correct data into a comprehensive, traceable, and reviewable evidence package.
Experimental records may be distributed across LIMS, ELNs, SDMS platforms, quality systems, archived reports, spreadsheets, and external scientific literature.
For a researcher examining a novel hypothesis or preparing for a quality review, finding relevant information often requires navigating multiple systems, verifying data lineage, reconciling inconsistent formats, and justifying the inclusion or exclusion of specific evidence.
While generative AI can help users draft or summarize content from a single prompt, Agentic AI expands this capability by coordinating defined, governed workflow stages across authorized data sources while ensuring review controls, provenance, and human accountability.
From generative AI to agentic workflows
In contrast to generative AI, which usually responds to individual requests, Agentic AI is engineered to execute a defined workflow objective within established boundaries. It can retrieve data from authorized sources, coordinate tasks across systems, assess novel inputs against defined criteria, and route findings to qualified experts when review or approval is needed.
Consider a team evaluating whether an existing therapy may be relevant to a novel disease indication. This evaluation may require historical experimental data, sample and instrument records, published literature, analytical results, quality documentation, and prior internal decisions.
Before acting, the team must identify relevant information, verify that it is current and authorized for use, and establish how each conclusion traces back to its underlying evidence.
Specialized AI agents can facilitate this workflow through multi-agent orchestration. One agent may retrieve and summarize relevant published literature; another may locate authorized internal lab records; and a third may check whether required quality or compliance documentation is present.
Rather than replacing scientific judgment, these specialized agents compile an organized evidence package with links to source materials, documented workflow activity, and clear escalation points for review by researchers or quality and regulatory teams.
The next AI revolution in life sciences isn't just about generating answers. It is about the rigorous, governed assembly of traceable evidence.”
Unlocking knowledge that already exists
For Agentic AI to operate reliably in life sciences, the underlying data foundation must link lab data with the context needed for interpretation and governance: sample history, experiment metadata, findings, quality records, audit information, controlled documents, methods, and user permissions.
An integrated LIMS, ELN, and SDMS ecosystem can provide this foundation by organizing lab data in governed systems of record. When AI agents access these systems via authorized, controlled interfaces, they can retrieve relevant data while respecting access controls, preserving source context, and maintaining a traceable record of how evidence was identified and utilized.
Governance, provenance, and human oversight
In regulated scientific settings, AI's value depends on more than its ability to retrieve or synthesize data. Every recommendation must be scientifically explainable, and all sources must be traceable. All workflow actions must be documented to support audit readiness, data integrity, and suitable validation requirements.
Governed agentic workflows should define which sources an agent can access, the specific actions it can carry out, when it should escalate an issue, and which user roles can review or approve an outcome.
Researchers and lab professionals remain responsible for analyzing evidence and making crucial decisions. Agentic AI can minimize the hands-on effort needed to find, organize, compare, and record data, though it should not obscure expert judgment or remove accountability from scientific workflows.
Where life sciences organizations can start
Life sciences organizations can start with bounded use cases that have clearly defined data sources, process stages, review roles, and anticipated outputs. Examples include identifying missing documentation, compiling traceable evidence packages, comparing findings across approved sources, retrieving historical research, and flagging items that require expert attention.
To assist organizations in navigating this transition, LabVantage has released a new framework, “Future-Proofing Life Sciences: The Strategic Imperative of Agentic AI in R&D”. This article offers a practical strategy for establishing trusted data foundations, defining human-in-the-loop controls, and integrating AI into high-value scientific and lab workflows.
For organizations looking to advance beyond isolated AI prompts, the practical question is how to integrate authorized scientific data, workflow governance, and expert review into a traceable operating model.
About LabVantage Solutions
LabVantage Solutions, Inc. is the leading global laboratory informatics provider. Our industry-leading LIMS and ELN solution and world-class services are the result of 35+ years of experience in laboratory informatics. LabVantage offers a comprehensive portfolio of products and services that enable companies to innovate faster in the R&D cycle, improve manufactured product quality, achieve accurate recordkeeping and comply with regulatory requirements.
LabVantage is a highly configurable, web-based LIMS/ELN that powers hundreds of laboratories globally, large and small. Built on a platform that is widely recognized as the best in the industry, LabVantage can support hundreds of concurrent users as well as interface with instruments and other enterprise systems. It is the best choice for industries ranging from pharmaceuticals and consumer goods to molecular diagnostics and bio banking. LabVantage domain experts advise customers on best practices and maximize their ROIs by optimizing LIMS implementation with a rapid and successful deployment.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.